首页> 外文期刊>Critical care medicine >Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index
【24h】

Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index

机译:医疗ICU患者急性肾损伤的可逆性:金属蛋白酶-2 X胰岛素样生长因子结合蛋白7和肾电图指数的尿组抑制剂的可预测性能

获取原文
获取原文并翻译 | 示例
           

摘要

Supplemental Digital Content is available in the text. Objectives: Urinary biomarkers and renal Doppler sonography remain considered as promising tools to distinguish transient from persistent acute kidney injury. The performance of the urinary biomarker, tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 and of renal resistive index to predict persistent acute kidney injury showed contradictory results. Our aim was to evaluate the performance of tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 and renal resistive index in predicting reversibility of acute kidney injury in critically ill patients. Design: Prospective observational study. Setting: Twenty-bed medical ICU in an university hospital. Patients: Consecutive patients with acute kidney injury. Intervention: None. Measurements and Main Results: Renal resistive index was measured within 12 hours after admission, and urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 was measured at H0, H6, H12, and H24. Renal dysfunction reversibility was evaluated at day 3. Receiver operating characteristic curves were plotted to evaluate diagnostic performance of renal resistive index and tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 to predict a persistent acute kidney injury. Overall, 100 patients were included in whom 50 with persistent acute kidney injury. Renal resistive index was higher in persistent acute kidney injury group. Urinary tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was not significantly different at each time between both groups. The performance of tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was poor with respectively an area under the receiver operating characteristic curves of 0.57 (95% CI, 0.45–0.68), 0.58 (95% CI, 0.47–0.69), 0.61 (95% CI, 0.50–0.72), and 0.57 (95% CI, 0.46–0.68) at H0, H6, H12, and H24. The area under the receiver operating characteristic curve for renal resistive index was 0.93 (95% CI, 0.89–0.98). A renal resistive index greater than or equal to 0.685 predicting persistent acute kidney injury with 78% (95% CI, 64–88%) sensitivity and 90% (95% CI, 78–97%) specificity. Conclusions: Renal resistive index had a good performance for predicting the reversibility of acute kidney injury in critically ill patients. Urinary tissue inhibitor of metalloproteinase-2 x insulin-like growth factor-binding protein 7 was unable to differentiate transient from persistent acute kidney injury.
机译:文本中提供了补充数字内容。目的:尿生物标志物和肾多普勒超声检查仍被视为有希望从持续的急性肾损伤区分短暂的工具。尿生物标志物的性能,金属蛋白酶-2 x胰岛素样生长因子结合蛋白7和预测持续急性肾损伤的肾脏电阻指数的组织抑制剂表现出矛盾的结果。我们的目的是评估金属蛋白酶-2 X胰岛素样生长因子结合蛋白7和肾电阻指标的组织抑制剂的性能,以预测临床病患者急性肾损伤的可逆性。设计:前瞻性观察研究。环境:大学医院二十床医疗ICU。患者:连续肾损伤的患者。干预:没有。测量和主要结果:在入院后12小时内测量肾电阻指数,并在H0,H6,H12和H 2 4下测量金属蛋白酶-2和胰岛素样生长因子结合蛋白7的尿组抑制剂。在第3天评估肾功能障碍可逆性。接收器操作特征曲线被绘制,评价肾电图酶和组织抑制剂对金属蛋白酶-2 X胰岛素样生长因子结合蛋白7的诊断性能,以预测持续的急性肾损伤。总体而言,100名患者含有50名患有持续急性肾损伤的患者。持续急性肾损伤组肾脏电阻指数较高。金属蛋白酶-2 X胰岛素样生长因子结合蛋白7在两组之间的每次在每次的情况下没有显着差异。金属蛋白酶-2 X胰岛素样生长因子结合蛋白7的组织抑制剂的性能分别在接收器下的接收器下的面积为0.57(95%CI,0.45-0.68),0.58(95%CI,0.47 -0.69),0.61(95%CI,0.50-0.72),H0,H6,H12和H24的0.57(95%CI,0.46-0.68)。接收器下的接收器的区域,用于肾电图指数的特性曲线为0.93(95%CI,0.89-0.98)。肾脏电阻指数大于或等于0.685预测持续急性肾损伤,78%(95%CI,64-88%)敏感性和90%(95%CI,78-97%)特异性。结论:肾脏电阻指数对预测患者患者急性肾损伤的可逆性具有良好的表现。金属蛋白酶-2 X胰岛素样生长因子结合蛋白7的尿组抑制剂无法区分瞬态急性肾损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号